EGFR Positive Non-Small Cell Lung Cancer,Adenocarcinoma
1 clinical trials · Condition
◉ Watch EGFR Positive Non-Small Cell Lung Cancer,Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC (NCT03402464) | Peking University Cancer Hospital & Institute | 2018-01-01 |
Track EGFR Positive Non-Small Cell Lung Cancer,Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.